Nanoparticles-based technologies for cholera detection and therapy

被引:3
作者
Ho, Nathan [1 ]
Tang, Kaitlyn [1 ]
Ngo, Vy [1 ]
Livits, Isabella [1 ]
Morrel, Alayne [1 ]
Noor, Bari [1 ]
Tseng, Kaylee [1 ]
Chung, Eun Ji [1 ,2 ,3 ,4 ,5 ,6 ,7 ]
机构
[1] Univ Southern Calif, Dept Biomed Engn, Los Angeles, CA 90089 USA
[2] Univ Southern Calif, Keck Sch Med, Dept Surg, Div Vasc Surg & Endovascular Therapy, Los Angeles 90033, CA USA
[3] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA
[4] Univ Southern Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell R, Keck Sch Med, Los Angeles, CA 90033 USA
[5] Univ Southern Calif, Keck Sch Med, Dept Med, Div Nephrol & Hypertens, Los Angeles, CA 90033 USA
[6] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90089 USA
[7] Univ Southern Calif, Dept Biomed Engn, 1042 Downey Way,DRB 140, Los Angeles, CA 90089 USA
来源
SLAS TECHNOLOGY | 2023年 / 28卷 / 06期
关键词
Vibrio cholerae; Cholera; Nanoparticles; Sensor-based diagnostics; Vaccines; VIBRIO-CHOLERAE; GOLD NANOPARTICLES; COLORIMETRIC DETECTION; TOXIN; DELIVERY; SUBUNIT; O1;
D O I
10.1016/j.slast.2023.10.006
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Cholera is a waterborne disease caused by Vibrio cholerae bacteria generally transmitted through contaminated food or water sources. Although it has been eradicated in most Western countries, cholera continues to be a highly transmitted and lethal disease in several African and Southeast Asian countries. Unfortunately, current diagnostic methods for cholera have challenges including high cost or delayed diagnoses that can lead to increased disease transmission during pandemics, while current treatments such as therapeutic drugs and vac-cines have limited efficacy against drug-resistant serogroups of Vibrio cholerae. As such, new solutions that can treat cholera in an efficient manner that avoids Vibrio cholerae's adaptive immunity are needed. Nanoparticles (NPs) are a suitable platform for enhancing current theranostic tools because of their biocompatibility and ability to improve drug circulation and targeting. Nanoparticle surfaces can also be modified with various protein re-ceptors targeting cholera toxins produced by Vibrio cholerae. This review will address recent developments in diagnostics, therapeutics, and prevention against cholera particularly focusing on the use of metal-based nanoparticles and organic nanoparticles. We will then discuss future directions regarding nanoparticle research for cholera.
引用
收藏
页码:384 / 392
页数:9
相关论文
共 67 条
[1]   Fluorescence energy transfer inhibition bioassay for cholera toxin based on galactose-stabilized gold nanoparticles and amine-terminated quantum dots [J].
Ahn, Kwang-Soo ;
Lim, Kyung Rae ;
Jeong, Daeho ;
Lee, Bo Young ;
Kim, Kwan Soo ;
Lee, Won-Yong .
MICROCHEMICAL JOURNAL, 2016, 124 :9-14
[2]  
[Anonymous], 2022, Cholera
[3]   Application of Caco-2 Cell Line in Herb-Drug Interaction Studies: Current Approaches and Challenges [J].
Awortwe, C. ;
Fasinu, P. S. ;
Rosenkranz, B. .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2014, 17 (01) :1-19
[4]   Investigation of the Antibacterial and Antibiofilm Activity of Selenium Nanoparticles against Vibrio cholerae as a Potent Therapeutics [J].
Bagheri-Josheghani, Sareh ;
Bakhshi, Bita .
CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY, 2022, 2022
[5]   Cholera Toxin B: One Subunit with Many Pharmaceutical Applications [J].
Baldauf, Keegan J. ;
Royal, Joshua M. ;
Hamorsky, Krystal Teasley ;
Matoba, Nobuyuki .
TOXINS, 2015, 7 (03) :974-996
[6]   A vaccine combination of lipid nanoparticles and a cholera toxin adjuvant derivative greatly improves lung protection against influenza virus infection [J].
Bernasconi, Valentina ;
Norling, Karin ;
Gribonika, Inta ;
Ong, Li Ching ;
Burazerovic, Sabina ;
Parveen, Nagma ;
Schon, Karin ;
Stensson, Anneli ;
Bally, Marta ;
Larson, Goran ;
Hook, Fredrik ;
Lycke, Nils .
MUCOSAL IMMUNOLOGY, 2021, 14 (02) :523-536
[7]   Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs [J].
Bhuiyan, NA ;
Qadri, F ;
Faruque, ASG ;
Malek, MA ;
Salam, MA ;
Nato, F ;
Fournier, JM ;
Chanteau, S ;
Sack, DA ;
Nair, GB .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (08) :3939-3941
[8]   Serogroup conversion of Vibrio cholerae in aquatic reservoirs [J].
Blokesch, Melanie ;
Schoolnik, Gary K. .
PLOS PATHOGENS, 2007, 3 (06) :733-742
[9]  
Centers for Disease Control and Prevention, 2022, Serotypes and the importance of serotyping salmonella
[10]   Immunogenicity of liposome-associated and refined antigen oral cholera vaccines in Thai volunteers [J].
Chaicumpa, W ;
Chongsa-nguan, M ;
Kalambaheti, T ;
Wilairatana, PA ;
Srimanote, P ;
Makakunkijcharoen, Y ;
Looareesuwan, S ;
Sakolvaree, Y .
VACCINE, 1998, 16 (07) :678-684